Overview on modern research of “Qin medicine”
10.7501/j.issn.0253-2670.2018.21.001
- Author:
Ben-Xiang HU
1
Author Information
1. College of Pharmacy, Shaanxi University of Chinese Medicine
- Publication Type:Journal Article
- Keywords:
Aconiti Lateralis Radix Praeparata;
Astragali Radix;
Bupleuri Radix;
Corni Fructus;
Corydalis Rhizoma;
Eucommiae Cortex;
Fraxini Cortex;
Gastrodiae Rhizoma;
Gentianae Macrophyllae Radix;
Polygonati Rhizoma;
Polyporus;
Qin medicine;
Quality control;
Resources of Chinese materia medica;
Salviae Miltiorrhizae Radix et Rhizoma;
Scutellariae Radix;
Taibaiqi medicine
- From:
Chinese Traditional and Herbal Drugs
2018;49(21):4949-4959
- CountryChina
- Language:Chinese
-
Abstract:
Shaanxi has a long history and profound cultural heritage. It has been referred to as “Qin” for a long time in history. Shaanxi is rich in medicinal plant resources, various main Chinese medicines such as Fraxini cortex, Gentianae Macrophyllae Radix, Ten “Qin medicine” (Astragali Radix in Zizhou County, Bupleuri Radix in Baoji, Corydalis Rhizoma in Yang County, Salviae Miltiorrhizae Radix et Rhizoma in Shangluo, Aconiti Lateralis Radix Praeparata in Hanzhong; Eucommiae Cortex in lueyang County; Gastrodiae Rhizoma in Ningshan County; Polyporus in Ningshan County; Scutellariae Radix in Chengcheng County; Corni Fructus in Foping County; Polygonati Rhizoma in Lueyang County) and “Taibaiqi medicine” are typically species of “Qin medicine”. In history, “Qin medicine” represents genuine medicinal materials produced from Shaanxi Province and the surrounding region. In recently, the industry of “Qin medicine” becomes one of the most valuable resources in Shaanxi, which also contributes to the integral part of Chinese medical and health services. Here, the research progress on germplasm resources, cultivation techniques, plantation base construction, variety breeding, bioactive compounds, and quality control of “Qin medicine” were integrated and reviewed, and its future development of “Qin medicine” was also prospected.
